{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:00:16Z","timestamp":1648602016518},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med","J. Jpn. Soc. Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/naika.103.2105","type":"journal-article","created":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T22:05:10Z","timestamp":1441836310000},"page":"2105-2110","source":"Crossref","is-referenced-by-count":0,"title":["2) Pathogenesis and Treatment of Immune-mediated Neuropathies; the Cutting Edge"],"prefix":"10.2169","volume":"103","author":[{"given":"Susumu","family":"Kusunoki","sequence":"first","affiliation":[{"name":"Department of Neurology, Kinki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2) Mitsui Y, et al:A multicenter prospective study of Guillain-Barr\u00e9 syndrome in Japan: a focus on the incidence of subtypes. J Neurol Neurosurg Psychiatry 2013, doi: 10.1136\/jnnp-2013-306509.[Epub ahead of print]","DOI":"10.1136\/jnnp-2013-306509"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Chiba A, et al: Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 31: 677-679, 1992.","DOI":"10.1002\/ana.410310619"},{"key":"3","doi-asserted-by":"publisher","unstructured":"4) Chiba A, et al: Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: Clinical and immunohistochemical studies. Neurology 43: 1911-1917, 1993.","DOI":"10.1212\/WNL.43.10.1911"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Kusunoki S, et al: Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 39: 424-431, 1996.","DOI":"10.1002\/ana.410390404"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Takada K, et al: Apoptosis of primary sensory neurons in GD1b-induced sensory ataxic neuropathy. Exp Neurol 209: 279-283, 2008.","DOI":"10.1016\/j.expneurol.2007.09.010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Yuki N, et al: A bacterium lipopolysaccharide that elicits Guillain-Barr\u00e9 syndrome has a GM1 ganglioside-like structure. J Exp Med 178: 1771-1775, 1993.","DOI":"10.1084\/jem.178.5.1771"},{"key":"7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.57.4.736","volume":"57","author":"S Kusunoki","year":"2001","unstructured":"8) Kusunoki S, et al: Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry. Neurology 57: 736-738, 2001.","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Kaida K, et al: Ganglioside complexes: as new target antigens in Guillain-Barr\u00e9 syndrome. Ann Neurology 56: 567-571, 2004.","DOI":"10.1002\/ana.20222"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10) Kaida K, Kusunoki S: Antibodies to gangliosides and ganglioside complexes in Guillain-Barr\u00e9 syndrome and Fisher syndrome: Mini-review. J Neuroimmunol 223: 5-12, 2010.","DOI":"10.1016\/j.jneuroim.2010.02.001"},{"key":"10","doi-asserted-by":"publisher","unstructured":"11) Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group: Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Lancet 349: 225-230, 1997.","DOI":"10.1016\/S0140-6736(96)09095-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"13) Joint Task Force of the EFNS and the PNS: European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J Peripher Nerv Syst 15: 1-9, 2010.","DOI":"10.1111\/j.1529-8027.2010.00245.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"14) Joint Task Force of the EFNS and the PNS: European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. J Peripher Nerv Syst 15: 295-301, 2010.","DOI":"10.1111\/j.1529-8027.2010.00290.x"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":["2\uff09\u514d\u75ab\u6027\u30cb\u30e5\u30fc\u30ed\u30d1\u30c1\u30fc\u306e\u75c5\u614b\u3068\u6cbb\u7642\u306e\u6700\u524d\u7dda"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/103\/9\/103_2105\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T09:20:26Z","timestamp":1567156826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/103\/9\/103_2105\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.103.2105","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}